BofA/Merrill Lynch Reinstates Emerson (EMR) at Neutral
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $109.62 -0.14%
Rating Summary:
24 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
24 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
BofA/Merrill Lynch reinstates coverage on Emerson (NYSE: EMR) with a Neutral. PT $55.00.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $50.65 yesterday.
For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.
Shares of Emerson closed at $50.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts GE Vernova (GEV) at Neutral, 'Multiyear turnaround amid positive demand backdrop'
- Berenberg Starts Lloyds TSB Group (LYG) at Hold
- Blackstone (BX) to Acquire Tropical Smoothie Cafe
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
